Friday Saidi

Our new Lancet correspondence urges prioritizing pregnant & breastfeeding women in HIV prevention using the “Two for Two” approach: just 2 LEN injections over 6 months to protect both mom & baby. thelancet.com/journals/lance…

New review: long-acting HIV drugs are safe for pregnant/breastfeeding women, with more trials including them. Injectable PrEP is entering maternal health. Policy and cost challenges remain. Read: rdcu.be/eAXGB #HIV #MaternalHealth #LongActingART

I have been featured in the HIV Prevention Trials Network (HPTN) April newsletter. Check out my guilty pleasure 😂😂😂😂 hptn.org/about/conversa…

On Monday, Dr. Friday Saidi moderated one of the sessions at the 2025 Conference for Retroviruses and Opportunistic Infections in San Francisco! 🌟 The discussion included: ▶️ Maternal Tenofovir for preventing infant Hepatitis B ▶️Home visit strategies to promote family health and couple HIV testing ▶️The pharmacokinetics, safety, and efficacy of Lenacapavir for PrEP in adolescents and adults (Purpose 1 trial) Congrats, Dr. Saidi, on a successful, well-attended discussion! 💬👏 @DrFridaySaidi | @unc_cwhr | #HIVresearch #obgyn

I am honored to have moderated a session on maternal and child health research at the ongoing #CROI2025 . The session was well-attended, featuring great presentations and engaging discussions. I am grateful for the opportunity to facilitate this important conversation!

Today we remember Professor James Gita Hakim on the 4th anniversary of his passing. He was a wonderful mentor and an inspiration to many people in the medical fraternity . May he rest in peace. 🙏🙏

Sharing our latest publication: a systematic review and narrative synthesis on the predictors of maternal HIV acquisition in sub-Saharan Africa. lnkd.in/dPwj9dky

African Women & #HIV 2025 conference. Call for abstracts. Please get yours in as submission deadline is fast approaching. Details👇🏿👇🏿👇🏿 @Academic_MedEdu @SWIFT_women @savoy__truffle @susancolehaley @SalamanderTrust @MakingWavesNet @ICW_Global @thewellproject 🙏🏾😊

“Oral PrEP maybe be altering the vaginal microbiota of pregnant women and predisposing them to the risk of preterm birth. A larger study is needed to confirm the findings.” says @DrFridaySaidi from the UNC Project - Malawi at #HIVR4P2024

Warm welcome to our new #BMCPregnancyChildbirth Editorial Board Members @DrFridaySaidi and @SmritiPrasad5. We are looking forward to working with you. Interested in joining #BMCPregnancyChildbirth? To find out more visit <…pregnancychildbirth.biomedcentral.com/about/join-us>

I am honored to have received the Honorary Lynne Mofenson Award for the Outstanding presentation at the International HIV and Pediatrics Workshop. This award includes a full travel scholarship that will allow me to attend the 2025 workshop in Kigali, Rwanda. #HIVPED

Excited to be speaking at the 16th International Workshop on Pediatrics & HIV from 19-20 July 2024 in Munich, Germany! Join the Discussion on What is New on Cabotegravir (CAB-LA) in Pregnancy: Progress on Implementation and Surveillance of Pregnancy Outcomes #HIVPED

Opportunity to join our team : globalhealth.unc.edu/malawi/malawi-…

This Thursday and Friday, we held a protocol training session for the O-PrEP study, a crucial initiative aimed at optimizing PrEP regimens for pregnant women in sub-Saharan Africa.

Her project will be an extension to the Pregnancy Infant and Maternal Health Outcome (PRIMO), with @DrFridaySaidi as her primary mentor. She will explore “facilitators and barriers to long-acting injectable PrEP use among pregnant and breastfeeding women”.

Glad to hear this 🙏

It’s a wrap for the inaugural African workshop on @HIV_and_Women. So many brilliant presentations, beautiful smiles, passionate people & candid testimonials. >400 delegates from 19 countries. Much food for thought. To be continued in Feb 2025, hope to see u there #HIVWOMENAFRICA

Happenning now! The Pregnancy, Breastfeeding and Contraception Session, exploring the Modern Contraceptive Options for Women on ART, and Does U=U Apply for Breastfeeding? #HIVWOMENAFRICA

Session 2 is underway focusing on HIV prevention; New Prevention Regimens and How they Affect HIV care, updates on PrEP and Breastfeeding Practices Among Women Living with HIV. #HIVWOMENAFRICA

Less than a week until #HIVWOMENAFRICA commences. Don't miss this hybrid workshop dedicated to enhancing the quality of life for women living with #HIV and reducing viral transmissions in Africa 👉bit.ly/48iFPTW